Royalty Pharma plc (RPRX) — Revenue

Annual figures by fiscal year, from SEC filings.

2018: $1.79B2019: $1.81B2020: $2.12B2021: $2.29B2022: $2.24B2023: $2.35B2024: $2.26B2025: $2.38B$2.38B
2018Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$2.38B+5.1%
2024$2.26B-3.9%
2023$2.35B+5.2%
2022$2.24B-2.3%
2021$2.29B+7.9%
2020$2.12B+17.0%
2019$1.81B+1.1%
2018$1.79B